Stem cell exosome treatment for recent stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests a new treatment using exosomes (tiny particles from stem cells) given through a vein to people who recently had an ischemic stroke. It aims to see if this treatment is safe and helps improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You had an ischemic stroke (a blockage in a blood vessel in the brain) within the last 72 hours.
- The stroke affects the part of the brain supplied by the internal carotid artery (a main artery in the neck that brings blood to the brain).
- Your stroke symptoms are mild to moderate — you can still walk and manage daily activities without help.
- Before the stroke, you were independent and could do all your daily activities without assistance.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new treatment using stem cells from donated umbilical cord tissue to help people recover from a recent moderate to severe stroke. It is for patients who cannot receive standard clot-busting treatments.
This study tests a new medicine made from tiny particles (neural exosomes) that may help the brain recover after a severe stroke. It is for people who had a large blood clot removed but still have significant disability shortly after the stroke.
This trial tests whether special cells from human placenta can help your brain recover after a recent stroke. The treatment is given as an injection and aims to reduce long-term disability.
This trial tests whether a single infusion of cells from umbilical cord blood (stem cells) can help people recover from a recent moderate-to-severe stroke. It aims to see if this treatment is safe and could improve recovery when given within the first two days after a stroke.
This trial tests an experimental treatment made from stem cells (exosomes) given within a week of a stroke, to see if it can help the brain recover. It is designed for people with moderate stroke symptoms who were otherwise healthy before the stroke.
This early-stage study (Phase 1) tests whether a tiny dose given through the nose is safe for people who have had a stroke. It uses exosomes made from adult umbilical cord stem cells, mainly to look for side effects and dosing safety.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.